Pepper Amber N, Bulkhi Adeeb, Smith Catherine R, Colli Matthias, Bergmann Karl-Christian, Zuberbier Torsten, Casale Thomas B
Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida.
Department of Internal Medicine, College of Medicine, Umm Al Qura University, Makkah, Saudi Arabia.
Allergy Rhinol (Providence). 2018 Sep 18;9:2152656718800060. doi: 10.1177/2152656718800060. eCollection 2018 Jan-Dec.
Vehicle interiors are an important microenvironment for atopic subjects. This study evaluated the subjective and objective physiologic and clinical effects of exposing subjects with asthma and allergic rhinitis to new 2017 Mercedes vehicles during 90-minute rides.
Ten adult asthmatics with allergic rhinitis were assessed before and 45 and 90 minutes into rides in a 2017 Mercedes-Benz S-Class sedan and GLE-Class SUV on 2 separate days. Assessments included spirometry, fractional exhaled nitric oxide, peak nasal inspiratory flow, asthma symptom scores, and physical examinations.
Of the 10 subjects, 6 were women, mean age was 32 years, and 6 and 4 were using chronic asthma controllers or intranasal corticosteroids, respectively. None of the subjects had worsening of asthma or rhinitis symptoms during the rides. There were no statistically significant changes from baseline in forced expiratory volume in 1 second, forced expiratory volume in 1 second:forced vital capacity ratio, forced expiratory flow at 25%-75% of vital capacity, fractional exhaled nitric oxide, or peak nasal inspiratory flow at 45 or 90 minutes into the rides with either Mercedes vehicle (all values > .1 using generalized linear mixed model).
The interior environment of the tested Mercedes vehicles did not cause changes in subjective or objective measures of asthma and allergic rhinitis. We suggest that this model system can be used to test other vehicles for putatively adverse effects on patients with allergic respiratory disorders.
汽车内部环境对于特应性个体来说是一个重要的微环境。本研究评估了哮喘和过敏性鼻炎患者在乘坐新款2017款梅赛德斯汽车90分钟期间的主观和客观生理及临床影响。
10名患有过敏性鼻炎的成年哮喘患者在2个不同日期乘坐2017款梅赛德斯 - 奔驰S级轿车和GLE级运动型多用途汽车,在乘车前、乘车45分钟和90分钟时接受评估。评估包括肺活量测定、呼出一氧化氮分数、鼻吸气峰流速、哮喘症状评分和体格检查。
10名受试者中,6名女性,平均年龄32岁,分别有6名和4名正在使用慢性哮喘控制药物或鼻内用皮质类固醇。在乘车期间,没有受试者的哮喘或鼻炎症状加重。在乘坐任何一款梅赛德斯汽车45分钟或90分钟时,一秒用力呼气量、一秒用力呼气量与用力肺活量比值、肺活量25%-75%时的用力呼气流量、呼出一氧化氮分数或鼻吸气峰流速与基线相比均无统计学显著变化(使用广义线性混合模型,所有P值>0.1)。
测试的梅赛德斯汽车内部环境未引起哮喘和过敏性鼻炎主观或客观指标的变化。我们建议该模型系统可用于测试其他车辆对过敏性呼吸道疾病患者的潜在不利影响。